Related Experiment Video
Updated: Jan 5, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Associations between miR-146a rs2910164 polymorphisms and risk of ischemic cardio-cerebrovascular diseases
Dongdong Zhao1, Yuerong Li1, Xiuyan Yu1
1Department of Cardiology, The Affiliated Hospital of Binzhou Medical University, Binzhou.
Insights
The miR-146a rs2910164 polymorphism is linked to a reduced risk of ischemic cardio-cerebrovascular diseases, particularly coronary heart disease. This genetic variant may serve as a valuable predictor for disease susceptibility.
Area of Science:
- Genetics
- Cardiovascular Epidemiology
- Molecular Biology
Background:
- Previous studies explored the link between miR-146a rs2910164 polymorphisms and ischemic cardio-cerebrovascular disease risk.
- Existing research findings on this association remain inconsistent.
Purpose of the Study:
- To conduct a comprehensive meta-analysis evaluating the relationship between miR-146a rs2910164 polymorphisms and the risk of ischemic cardio-cerebrovascular diseases.
- To clarify the inconsistent findings from previous individual studies.
Main Methods:
- A systematic literature search was performed across multiple databases (PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, VIP, Wanfang).
- Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the strength of associations.
- Statistical analyses included heterogeneity, sensitivity, and publication bias assessments to ensure robustness.
Main Results:
- The meta-analysis included 26 studies with 11,602 cases and 14,016 controls.
- miR-146a rs2910164 polymorphisms were significantly associated with a reduced risk of coronary heart disease (CHD) across all genetic models.
- A reduced risk of ischemic cardio-cerebrovascular diseases was also observed in subgroup analyses of large sample sizes.
Conclusions:
- miR-146a rs2910164 polymorphisms are significantly associated with a lower risk of ischemic cardio-cerebrovascular diseases.
- This specific polymorphism may be a potential predictive marker for susceptibility to these vascular conditions.
Background:
Many studies investigated the association between miR-146a rs2910164 polymorphisms and risk of ischemic cardio-cerebrovascular diseases. However, the results were inconsistent.
Methods:
We searched the PubMed, EMBASE, Cochrane library, Web of Science, Chinese National Knowledge Infrastructure, VIP, and Wanfang databases for appropriate studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the associations. Heterogeneity, sensitivity, and publication bias were conducted to measure the robustness of our findings.All analyses were based on previous published studies, thus, no ethical approval and patient consent are required.
Results:
We conducted a meta-analysis to evaluate the relationship between miR-146a rs2910164 polymorphisms and risk of ischemic cardio-cerebrovascular diseases. A total of 26 related studies involving 11,602 cases and 14,016 controls were identified and included in our meta-analysis. After considering the heterogeneity of the global analysis, we inferred that rs2910164 polymorphisms were associated with a lower risk of coronary heart disease (CHD) significantly in all genetic models. In addition, it was also found that the miR-146a rs2910164 polymorphisms were associated with the low risk of ischemic cardio-cerebrovascular diseases in large sample size subgroup analysis.
Conclusion:
These results indicate that miR-146a rs2910164 polymorphisms were significantly associated with a lower risk of ischemic cardio-cerebrovascular. The miR-146a rs29101164 might be recommended as a predictor for susceptibility of ischemic cardio-cerebrovascular diseases.
More Related Videos
07:00A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Coronary Artery Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Imaging Studies for Cardiovascular System IV: CMRI
Single Nucleotide Polymorphisms-SNPs
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...